Glenmark Pharmaceuticals Sees Surge in Active Call Options with 7,794 Contracts at Rs 2,000

Glenmark Pharmaceuticals Ltd. has emerged as one of the most active stocks today, particularly in the options market. The company, operating within the Pharmaceuticals & Biotechnology sector, has seen significant trading activity in call options set to expire on September 30, 2025. Notably, 7,794 contracts were traded at a strike price of Rs 2,000, contributing to a turnover of approximately Rs 1,596.70 lakhs. The underlying value of Glenmark's stock is currently at Rs 1,991.20, with an open interest of 1,257 contracts.
In terms of performance metrics, Glenmark has outperformed its sector by 2.9% today, with the stock reaching an intraday high of Rs 2,006, reflecting a 4.54% increase. The stock's price is currently above its 5-day, 50-day, 100-day, and 200-day moving averages, although it remains below the 20-day moving average. However, there has been a notable decline in investor participation, with delivery volume dropping by 56.8% compared to the 5-day average.

Overall, Glenmark Pharmaceuticals continues to show robust trading activity, underscoring its position in the mid-cap market with a market capitalization of Rs 55,134 crore.